Creative Planning’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.15M Buy
140,177
+37,491
+37% +$2.04M 0.01% 829
2025
Q4
$4.74M Buy
102,686
+22,363
+28% +$1M ﹤0.01% 1040
2025
Q3
$2.89M Buy
80,323
+1,853
+2% +$61.4K ﹤0.01% 1251
2025
Q2
$2.55M Buy
78,470
+39,491
+101% +$1.29M ﹤0.01% 1145
2025
Q1
$1.47M Sell
38,979
-7,842
-17% -$627K ﹤0.01% 1413
2024
Q4
$3.83M Buy
46,821
+9,296
+25% +$923K ﹤0.01% 773
2024
Q3
$4.29M Buy
37,525
+10,245
+38% +$923K ﹤0.01% 692
2024
Q2
$2.06M Buy
27,280
+10,642
+64% +$724K ﹤0.01% 970
2024
Q1
$1.14M Buy
16,638
+4,688
+39% +$325K ﹤0.01% 1254
2023
Q4
$750K Buy
11,950
+2,875
+32% +$149K ﹤0.01% 1426
2023
Q3
$463K Buy
9,075
+2,634
+41% +$130K ﹤0.01% 1616
2023
Q2
$322K Buy
+6,441
New +$305K ﹤0.01% 1857
2023
Q1
Sell
-4,269
Closed -$205K 2740
2022
Q4
$205K Buy
+4,269
New +$168K ﹤0.01% 2004

Other funds holding PCVX